These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37726387)

  • 1. Ribosomal S6 protein kinase 4 promotes resistance to EZH2 inhibitors in glioblastoma.
    Pang F; Zhang L; Li M; Yi X; Wang Y; Yang P; Wen B; Jiang J; Teng Y; Yang X; Chen L; Xu J; Wang L
    Cancer Gene Ther; 2023 Dec; 30(12):1636-1648. PubMed ID: 37726387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.
    Yu T; Zhou F; Tian W; Xu R; Wang B; Zeng A; Zhou Z; Li M; Wang Y; Zhang J
    Oncogene; 2023 Feb; 42(6):461-470. PubMed ID: 36517590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelial-mesenchymal transition, migration, and on the pro-inflammatory phenotype.
    Stazi G; Taglieri L; Nicolai A; Romanelli A; Fioravanti R; Morrone S; Sabatino M; Ragno R; Taurone S; Nebbioso M; Carletti R; Artico M; Valente S; Scarpa S; Mai A
    Clin Epigenetics; 2019 Dec; 11(1):173. PubMed ID: 31791385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. n-Butylidenephthalide Regulated Tumor Stem Cell Genes EZH2/AXL and Reduced Its Migration and Invasion in Glioblastoma.
    Yen SY; Chuang HM; Huang MH; Lin SZ; Chiou TW; Harn HJ
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM37 interacts with EZH2 to epigenetically suppress PTCH1 and regulate stemness in glioma stem cells through sonic hedgehog pathway.
    Cai L; Liu Y; Li Y; Liu B; Cao Y; Yang W; Wang B; Sun T
    J Neurooncol; 2024 Sep; 169(2):269-279. PubMed ID: 38884661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
    Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
    Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.
    Wang J; Cheng P; Pavlyukov MS; Yu H; Zhang Z; Kim SH; Minata M; Mohyeldin A; Xie W; Chen D; Goidts V; Frett B; Hu W; Li H; Shin YJ; Lee Y; Nam DH; Kornblum HI; Wang M; Nakano I
    J Clin Invest; 2017 Aug; 127(8):3075-3089. PubMed ID: 28737508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2 regulates the malignancy of human glioblastoma cells via modulation of Twist mRNA stability.
    Zhai X; Li LS; Zhou YD; Ji WY; Chen H; Xiao H; Liang P
    Eur J Pharmacol; 2021 Aug; 904():174177. PubMed ID: 34015321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1.
    Luo W; Li X; Song Z; Zhu X; Zhao S
    Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis.
    Chen X; Hao A; Li X; Du Z; Li H; Wang H; Yang H; Fang Z
    J Pineal Res; 2016 Sep; 61(2):208-17. PubMed ID: 27121240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EZH2 is essential for glioblastoma cancer stem cell maintenance.
    Suvà ML; Riggi N; Janiszewska M; Radovanovic I; Provero P; Stehle JC; Baumer K; Le Bitoux MA; Marino D; Cironi L; Marquez VE; Clément V; Stamenkovic I
    Cancer Res; 2009 Dec; 69(24):9211-8. PubMed ID: 19934320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.
    Orzan F; Pellegatta S; Poliani PL; Pisati F; Caldera V; Menghi F; Kapetis D; Marras C; Schiffer D; Finocchiaro G
    Neuropathol Appl Neurobiol; 2011 Jun; 37(4):381-94. PubMed ID: 20946108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
    Li Q; Dong C; Cui J; Wang Y; Hong X
    J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination LSD1 and HOTAIR-EZH2 inhibition disrupts cell cycle processes and induces apoptosis in glioblastoma cells.
    Zhao J; Jin W; Yi K; Wang Q; Zhou J; Tan Y; Xu C; Xiao M; Hong B; Xu F; Zhang K; Kang C
    Pharmacol Res; 2021 Sep; 171():105764. PubMed ID: 34246782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.
    Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ
    Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamine deprivation in glioblastoma stem cells triggers autophagic SIRT3 degradation to epigenetically restrict CD133 expression and stemness.
    Xing Z; Jiang X; Chen Y; Wang T; Li X; Wei X; Fan Q; Yang J; Wu H; Cheng J; Cai R
    Apoptosis; 2024 Oct; 29(9-10):1619-1631. PubMed ID: 39068621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting EZH2 regulates the biological characteristics of glioma stem cells via the Notch1 pathway.
    Zhao G; Deng Z; Li X; Wang H; Chen G; Feng M; Zhou Y
    Exp Brain Res; 2023 Oct; 241(10):2409-2418. PubMed ID: 37644332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No Significant Cytotoxic Effect of the EZH2 Inhibitor Tazemetostat (EPZ-6438) on Pediatric Glioma Cells with Wildtype Histone 3 or Mutated Histone 3.3.
    Wiese M; Schill F; Sturm D; Pfister S; Hulleman E; Johnsen SA; Kramm CM
    Klin Padiatr; 2016 Apr; 228(3):113-7. PubMed ID: 27135271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria-targeting nano therapy altering IDH2-mediated EZH2/EZH1 interaction as precise epigenetic regulation in glioblastoma.
    Kaundal B; Karmakar S; Roy Choudhury S
    Biomater Sci; 2022 Sep; 10(18):5301-5317. PubMed ID: 35917200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.